BioSpace News Archive

FDA

2022’s Top 5 FDA Drug Approvals are Major Advancements in Cancer, Cardiovascular Disease and Rare Disorders

The FDA’s top five approvals in 2022 represent an eclectic mix of cancer, cardiovascular and rare disease drugs.

December 22, 2022
·
4 min read
·
Editorial Staff
Drug Development

Lexicon’s AAK1 Inhibitor Disappoints in Phase II Postherpetic Neuralgia Study

Lexicon Pharmaceuticals’ LX9211 fell short of its primary efficacy endpoint, according to topline data from the Phase II RELIEF-PHN-1 study in post-herpetic neuralgia.

December 22, 2022
·
2 min read
·
Tristan Manalac
Business

BioSpace’s Top Biopharma M&A Candidates for 2023

Mergers and acquisitions are expected to be a key theme in the pharmaceutical industry in 2023.

December 22, 2022
·
7 min read
·
Heather McKenzie and George Budwell
How a US Recession Could Affect Biopharma

U.S. recession will inevitably make many biopharma companies change course. However, it could cause some biotechs to change for the better.

December 22, 2022
·
5 min read
·
Christie Adams
I Peace, Inc. honored in BioSpectrum Asia Excellence Award 2022 with “Special Recognition in Cell Therapy”

I Peace, Inc. is a Palo Alto-based biotech company focusing on Nobel Prize-winning technology of induced pluripotent stem cells (iPSCs) and has successfully developed a novel system to mass manufacture clinical-grade iPSCs for cell therapy in a palm-sized closed cassette.

December 22, 2022
·
2 min read
Business

Merck Expands ADC Footprint with $9.3B Kelun Licensing Deal

Merck entered into a license and collaboration agreement with Chinese company Kelun-Biotech to develop seven antibody-drug conjugates candidates against oncology targets.

December 22, 2022
·
2 min read
·
Tristan Manalac
Business

Eli Lilly Expands RNA Editing Collaboration with ProQR Therapeutics

Eli Lilly and ProQR Therapeutics expand their RNA-editing collaboration.

December 22, 2022
·
1 min read
·
Alex Keown
IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 5, 2023.

December 22, 2022
·
1 min read
Genetown

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 22, 2022

Spero Therapeutics, Inc. announced that on December 19, 2022, the Compensation Committee of Spero’s Board of Directors approved a grant of 155,000 restricted stock unit awards to one new employee under the Spero Therapeutics, Inc.

December 22, 2022
·
2 min read
Bio NC

UNC Health Provider Ushers in First FDA-Approved Medication for Eosinophilic Esophagitis

Eosinophilic esophagitis (EoE) is an allergic condition of the esophagus that is on the rise throughout the United States. Patients with the condition typically have inflammation throughout their esophagus and trouble swallowing food – known as dysphagia.

December 22, 2022
·
6 min read